![Apixaban Intermediate CAS 27143-07-3 Ethyl Chloro[(4-Methoxyphenyl)hydrazono]acetate puritatis ≥99.0% (HPLC) Image Featured](https://www.ruifuchemical.com/uploads/Apixaban-Intermediate-CAS-490-46-0-Factory-Shanghai-Ruifu-Chemical-Co.-Ltd.-www.ruifuchem.com_.jpg)
Apixaban Intermedia CAS 27143-07-3 Ethyl Chloro [(4-Methoxyphenyl)hydrazono]acetate puritatis ≥99.0% (HPLC)
Ruifu Chemical primarius est elit Ethyl Chloro [(4-Methoxyphenyl)hydrazono] acetatis (CAS: 27143-07-3) cum qualitate media Apixaban (CAS: 503612-47-3).Ruifu partus terrarum, quantitatis competitive pretium, parvas et parvas quantitates in promptu habere potest.Purchase Apixaban intermedia, E-mail: alvin@ruifuchem.com
| Nomen chemicum | Ethyl Chloro[(4-Methoxyphenyl)hydrazono]acetate |
| Synonyma | Ethyl 2-Chloro-2-[2-(4-Methoxyphenyl)hydrazono]acetate;(Z)-Ethyl 2-Chloro-2-(2-(4-Methoxyphenyl)hydrazono)acetate;2-Chloro-2-[2-(4-Methoxyphenyl)hydrazinylidene];Apixaban-2;Apixaban Impuritas 3 |
| Stock Status | In Stock, Commercial Productio |
| CAS Number | 27143-07-3 |
| Formulae hypotheticae | C11H13ClN2O3 |
| M. Pondus | 256.69 g/mol |
| Liquescens punctum | 94℃ |
| Density | 1.23 |
| COA & MSDS | Praesto |
| Origin | Shanghai, China |
| Categoria | Apixaban (CAS: 503612-47-3) |
| Brand | Ruifu Chemical |
| Items | Signa inspectionis | Proventus |
| Aspectus | Lux Yellow ad Yellow pulverem | Obsequitur |
| Damnum in Siccatio | <0.50% | 0.23% |
| Puritas / Analysis Methodus | ≥99.0% (HPLC) | 99.3% |
| Infrared Imaginis | Conformat ut Structure | Obsequitur |
| 1 H NMR Spectrum | Congruunt Structure | Obsequitur |
| conclusio | Productum probatum est & obsequitur datis specificationibus | |
Sarcina:Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Continentem arcte clausam et in loco frigido, sicco (2~8℃) reponunt et a cellis bene ventilatis ab substantiis incompossibilibus.A luce et humore protege.
Naviportans:Libera ad mundum ab aere, per FedEx / DHL Express.Ieiunium et certas traditiones provide.
Index solutionum in Vestibulum
| Nec. | Nomen | CAS Non. | Formulae hypotheticae |
| 1 | Ethyl Acetate | CAS: 141-78-6 | C4H8O2 |
| 2 | Dichloromethane | CAS: 75-09-2 | CH2Cl2 |
| 3 | Ethyl Sin | CAS: 64-17-5 | C2H5OH |
5.3.1 Aspectus: Lumen luteum esse debet in luteum pulveris.Visu, sufficientem quantitatem ementiti producti (sine pondo) in disco cristallo vitreo pone in background alba (veluti charta alba) sub lumine naturali.
5.3.2 Lepidium sativum: 1H-NMR eandem structuram ac vexillum habet.10~15 mg sample appensum in tubo magnetico nuclei, et 0.5mL deuterii DMSO ad exemplum plene solvendum accessit, et deinde cum resonantia magnetica plus quam 400MHz instrumentum nuclei probatum est.
5.3.3 Damnum in siccitate : expende specimen circa 1.0g et eam sicca pro 3h in clibano siccendo ad 85℃.Operatio specifica pro pondus damnum calculi praestabitur secundum praescripta SOP-AP-QC-002-01 ad Determinationem Siccationis Pondus Damni.
5.3.4.1 Conditiones chromatographicae:
Test reagentia: 1) acetonitrile pro chromatographia 2) aqua purificata 3) acidum phosphoricum
Columna: WondaCract ODS-2 4.6*250mm*5um (8520-39993)
Mobilis pars: A: Accurate metimur 1.0ml acidum phosphoricum et 1000ml aquam, degassing ultrasonicum sparguntur.
B: Acetonitrile.
Gradiente procedure: sequenti mensa
Tempus mobile tempus A (%) tempus mobile B (%)
3 90 10
10 25 75
20 0 100
25 0 100
Detector: 210nm
Columna temperatus: 35℃
Celeritas fluat: 1.0ml/min
Magnitudo exempli: 5µl
5.3.4.2 Solutio praeparationis:
5.3.4.3 diluens: acetonitrile
5.3.4.4 Blank solutio: diluens solutione blank utendum est.
5.3.4.5 Solutio producti probati: Appende productum experimentum circa 12.5mg in utre 25ml voluminetric et diluente ad libram dissolve.
5.3.4.6 Operatio processus: Post basilineum instrumenti stabilis est, una ad duas injectiones solutionis blank educitur, et tunc solutio operis testi resolvitur.Chromatogram servatur et resolvitur, apicem blank detrahitur, et culmen puritatis et singularis immunditia consequitur in chromatogramma testi producti per modum ordinationis area notantur.Post analysim, chromatogrammum impressum est.
Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Ethyl Chloro [(4-Methoxyphenyl)hydrazono]acetate (CAS: 27143-07-3) ut medium adhibetur in synthesi Apixaban (CAS: 503612-47-3).Apixaban novum genus factoris oralis Xa inhibitoris coniunctim evolvit a Bristol-Myers Squibb et Pfizer.Nomen artis Erroto est.Novum genus anticoagulantis oralis est.Inhibendo factorem coagulationis magni Xa, apixaban productionem et thrombosis thrombin impedire potest.Apixaban a Bristal-Myers squibb Company evoluta est.Bonum bioavailability et altum selectivity habet.Apixaban in Sinis recensetur anno 2013. possibilitas commercii medicamentorum minima est possibilitas commercii, et multae modi sunt ad tollendam illam, quae expectatur utendum in peculiaribus coetibus laborantibus iecoris morbo aut renis damno.
![Apixaban Intermedia CAS 27143-07-3 Ethyl Chloro [(4-Methoxyphenyl)hydrazono]acetate puritatis ≥99.0% (HPLC)](https://www.ruifuchemical.com/uploads/Apixaban-Intermediate-CAS-490-46-0-Factory-Shanghai-Ruifu-Chemical-Co.-Ltd.-www.ruifuchem.com_-300x300.jpg)
